MEMPHIS, Tenn., June 2, 2015 (GLOBE NEWSWIRE) -- Comprehensive Pharmacy Services (CPS), the nation's largest pharmacy services provider, today announced the appointment of Sam Daniel, CPA, as Chief Financial Officer. The company, which was founded over 40 years ago, is positioning for accelerated growth as hospitals in the U.S. seek new ways to address clinical, operational and financial performance challenges.
"As hospitals and systems of all sizes transform themselves in a rapidly evolving marketplace, many are realizing that pharmacy operations play a pivotal role in that process, and they are turning to CPS as the industry leader in hospital pharmacy solutions," said Don Nickleson, chief executive officer of CPS. "That's led to accelerated growth opportunities for CPS and the need for a CFO of Sam Daniel's caliber. I've known Sam for years and I am confident that he will provide CPS with the strategic financial leadership we need to support our growth and continued high level of service to our clients."
As the CPS CFO, Daniel will be responsible for accounting and finance, treasury and cash management, planning and budgeting, and asset management. He has more than 35 years of finance and accounting experience. Most recently, he was the chief financial officer for American Pathology Partners, a private equity backed anatomic pathology company, and also brings extensive experience in the specialty pharmacy and specialty lab sectors of the industry.
"CPS has been the proven leader in hospital pharmacy services for nearly half a century, yet it is facing high growth potential as if it were a new company entering a new industry sector, and that's very exciting," Daniel said. "The dynamics in the hospital marketplace today are such that CPS is well positioned to provide hospitals of any size anywhere in the country with new savings and revenue opportunities and improved clinical and patient satisfaction results. I'm looking forward to helping the CPS team meet the needs of their existing and new clients while providing the financial infrastructure to achieve CPS' growth objectives."
Daniel has had extensive healthcare industry experience in financial leadership roles. He has served as chief financial officer and a founder of Regional Diagnostic Laboratories, Inc., a private equity-backed company focused on acquiring and operating clinical laboratories. Prior to that, he was a founder and the chief financial officer for OralDNA Labs Inc., a privately held salivary diagnostic company formed to provide clinical laboratory tests to the dental market. He also served as the chief financial officer of American Esoteric Laboratories, Inc. a clinical laboratory company primarily focused on acquiring and operating hospital outreach laboratories. Previously, he was the controller for publically held Accredo Health, Inc. a specialty pharmacy distribution company with both revenues and market capitalization exceeding $2 billion. Prior to entering the healthcare industry, he served as CFO of an office supplies and furniture distribution company, as corporate controller of a manufacturing company and progressed to the level of senior manager in the public accounting firm, Rhea & Ivy, CPAs. He earned his BS in accounting from Freed-Hardeman University.
About Comprehensive Pharmacy Services:
Employing over 1,900 pharmacy professionals, CPS is the nation's largest provider of pharmacy services to more than 400 hospitals and healthcare facilities leading to improved financial results, enhanced quality and risk management. CPS services include pharmacy consulting and regulatory services, 340B solutions, inpatient and outpatient pharmacy solutions, telepharmacy services and medication related transition of care services. For more information, visit cpspharm.com.
CONTACT: Rod Recor Vice President, Product Development and Marketing Rod.Recor@cpspharm.com 901-748-0470 Office
Source: Comprehensive Pharmacy Services